| Intensive insulin therapy and pentastarch resuscitation in severe sepsis FM Brunkhorst, C Engel, F Bloos, A Meier-Hellmann, M Ragaller, N Weiler, ... New England Journal of Medicine 358 (2), 125-139, 2008 | 3853 | 2008 |
| CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by … M Pfreundschuh, L Trümper, A Österborg, R Pettengell, M Trneny, K Imrie, ... The lancet oncology 7 (5), 379-391, 2006 | 2573 | 2006 |
| Stem cells: attributes, cycles, spirals, pitfalls and uncertainties lessons for and from the crypt CS Potten, M Loeffler Development 110 (4), 1001-1020, 1990 | 2474 | 1990 |
| Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes B Chapuy, C Stewart, AJ Dunford, J Kim, A Kamburov, RA Redd, ... Nature medicine 24 (5), 679-690, 2018 | 1691 | 2018 |
| Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60) M Pfreundschuh, J Schubert, M Ziepert, R Schmits, M Mohren, ... The lancet oncology 9 (2), 105-116, 2008 | 1325 | 2008 |
| A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling M Hummel, S Bentink, H Berger, W Klapper, S Wessendorf, TFE Barth, ... New England Journal of Medicine 354 (23), 2419-2430, 2006 | 1205 | 2006 |
| Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease V Diehl, J Franklin, M Pfreundschuh, B Lathan, U Paulus, D Hasenclever, ... New England Journal of Medicine 348 (24), 2386-2395, 2003 | 1154 | 2003 |
| Epidemiology of sepsis in Germany: results from a national prospective multicenter study C Engel, FM Brunkhorst, HG Bone, R Brunkhorst, H Gerlach, S Grond, ... Intensive care medicine 33, 606-618, 2007 | 1151 | 2007 |
| Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the … C Hartmann, B Hentschel, W Wick, D Capper, J Felsberg, M Simon, ... Acta neuropathologica 120, 707-718, 2010 | 986 | 2010 |
| Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL M Pfreundschuh, L Trümper, M Kloess, R Schmits, AC Feller, C Rübe, ... Blood 104 (3), 634-641, 2004 | 895 | 2004 |
| Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial F Edelmann, R Wachter, AG Schmidt, E Kraigher-Krainer, C Colantonio, ... Jama 309 (8), 781-791, 2013 | 884 | 2013 |
| CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the … M Pfreundschuh, E Kuhnt, L Trümper, A Österborg, M Trneny, L Shepherd, ... The lancet oncology 12 (11), 1013-1022, 2011 | 875 | 2011 |
| Exercise training improves exercise capacity and diastolic function in patients with heart failure with preserved ejection fraction: results of the Ex-DHF (Exercise training in … F Edelmann, G Gelbrich, HD Düngen, S Fröhling, R Wachter, ... Journal of the American College of Cardiology 58 (17), 1780-1791, 2011 | 812 | 2011 |
| Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes A Xue, Y Wu, Z Zhu, F Zhang, KE Kemper, Z Zheng, L Yengo, ... Nature communications 9 (1), 2941, 2018 | 778 | 2018 |
| Standard International Prognostic Index Remains a Valid Predictor of Outcome for Patients With Aggressive CD20+ B-Cell Lymphoma in the Rituximab Era M Ziepert, D Hasenclever, E Kuhnt, B Glass, N Schmitz, M Pfreundschuh, ... Journal of clinical oncology 28 (14), 2373-2380, 2010 | 764 | 2010 |
| Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network M Weller, J Felsberg, C Hartmann, H Berger, JP Steinbach, J Schramm, ... Journal of Clinical Oncology 27 (34), 5743-5750, 2009 | 756 | 2009 |
| Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake M Loeffler, JA Krüger, AG Niethammer, RA Reisfeld The Journal of clinical investigation 116 (7), 1955-1962, 2006 | 729 | 2006 |
| Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma … N Schmitz, L Trümper, M Ziepert, M Nickelsen, AD Ho, B Metzner, N Peter, ... Blood, The Journal of the American Society of Hematology 116 (18), 3418-3425, 2010 | 723 | 2010 |
| A catalog of genetic loci associated with kidney function from analyses of a million individuals M Wuttke, Y Li, M Li, KB Sieber, MF Feitosa, M Gorski, A Tin, L Wang, ... Nature genetics 51 (6), 957-972, 2019 | 692 | 2019 |
| MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma H Horn, M Ziepert, C Becher, TFE Barth, HW Bernd, AC Feller, W Klapper, ... Blood, The Journal of the American Society of Hematology 121 (12), 2253-2263, 2013 | 649 | 2013 |
